Amphastar Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $631.2M
Liabilities Breakdown FY2020
Total Liabilities: $182.5M
Asset Breakdown
Total Assets: $631.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $92.6M | 14.7% |
| Accounts Receivable | $66.0M | 10.5% |
| Inventory | $96.8M | 15.3% |
| Property, Plant & Equipment | $260.1M | 41.2% |
| Goodwill | $3.9M | 0.6% |
| Intangible Assets | $7.5M | 1.2% |
| Other Assets | $104.3M | 16.5% |
Liabilities Breakdown
Total Liabilities: $182.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $24.4M | 13.3% |
| Long-Term Debt | $45.9M | 25.2% |
| Other Liabilities | $112.2M | 61.5% |